Bewel 20mg

Bewel 20mg: A Comprehensive Overview.

Bewel 20mg is a medication designed to help manage blood sugar levels in adults with type 2 diabetes mellitus. It works by inhibiting the sodium-glucose co-transporter 2 (SGLT2) in the kidneys, which helps the body remove excess glucose through urine, thereby lowering blood sugar levels.

Key Information

• Indication: Improves glycemic control in adults with type 2 diabetes mellitus.
• Dosage: The recommended dose is 20mg taken once daily in the morning, with or without food. Do not crush or chew the tablet.
• Contraindications: Not recommended for patients with type 1 diabetes mellitus, as it may increase the risk of diabetic ketoacidosis. Also contraindicated in patients on dialysis.
• Renal Function: Assess renal function before initiating treatment and periodically thereafter. BRENZAVVY is not recommended for patients with an eGFR less than 30 mL/min/1.73 m².
• Volume Depletion: Correct volume depletion before starting treatment to avoid potential complications.
• Side Effects: Assess patients who present with signs and symptoms of metabolic acidosis for ketoacidosis, regardless of blood glucose level. Discontinue and evaluate if suspected.

Important Considerations

• Monitoring: Regularly monitor renal function and correct volume depletion as necessary.
• Interactions: Consult your healthcare provider about potential interactions with other medications.
• Patient Counseling: Refer to the patient counseling information and medication guide for detailed instructions.

Bewel 20mg is an effective tool for managing type 2 diabetes, but it is crucial to follow the recommended dosage and monitoring guidelines to ensure safe and effective use.